1 line
20 KiB
Plaintext
1 line
20 KiB
Plaintext
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T16:39:25Z","timestamp":1704472765230},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["377869","426534"]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Rare neurodevelopmental disorders, including inherited white matter disorders or leukodystrophies, often present a diagnostic challenge on a genetic level given the large number of causal genes associated with a range of disease subtypes. This study aims to demonstrate the challenges and lessons learned in the genetic investigations of leukodystrophies through presentation of a series of cases solved using exome or genome sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Each of the six patients had a leukodystrophy associated with hypomyelination or delayed myelination on MRI, and inconclusive clinical diagnostic genetic testing results. We performed next generation sequencing (case-based exome or genome sequencing) to further investigate the genetic cause of disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Following different lines of investigation, molecular diagnoses were obtained for each case, with patients harboring pathogenic variants in a range of genes including <jats:italic>TMEM106B, GJA1, AGA, POLR3A<\/jats:italic>, and <jats:italic>TUBB4A<\/jats:italic>. We describe the lessons learned in reaching the genetic diagnosis, including the importance of (a) utilizing proper multi-gene panels in clinical testing, (b) assessing the reliability of biochemical assays in supporting diagnoses, and (c) understanding the limitations of exome sequencing methods in regard to CNV detection and region coverage in GC-rich areas.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study illustrates the importance of applying a collaborative diagnostic approach by combining detailed phenotyping data and metabolic results from the clinical environment with advanced next generation sequencing analysis techniques from the research environment to increase the diagnostic yield in patients with genetically unresolved leukodystrophies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1148377","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:43:59Z","timestamp":1680536639000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Solving inherited white matter disorder etiologies in the neurology clinic: Challenges and lessons learned using next-generation sequencing"],"prefix":"10.3389","volume":"14","author":[{"given":"Stefanie","family":"Perrier","sequence":"first","affiliation":[]},{"given":"Kether","family":"Guerrero","sequence":"additional","affiliation":[]},{"given":"Luan T.","family":"Tran","sequence":"additional","affiliation":[]},{"given":"Mackenzie A.","family":"Michell-Robinson","sequence":"additional","affiliation":[]},{"given":"Genevi\u00e8ve","family":"Legault","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Brais","sequence":"additional","affiliation":[]},{"given":"Michel","family":"Sylvain","sequence":"additional","affiliation":[]},{"given":"James","family":"Dorman","sequence":"additional","affiliation":[]},{"given":"Michelle","family":"Demos","sequence":"additional","affiliation":[]},{"given":"Wolfgang","family":"K\u00f6hler","sequence":"additional","affiliation":[]},{"given":"Tomi","family":"Pastinen","sequence":"additional","affiliation":[]},{"given":"Isabelle","family":"Thiffault","sequence":"additional","affiliation":[]},{"given":"Genevi\u00e8ve","family":"Bernard","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymgme.2015.01.006","article-title":"Case definition and classification of leukodystrophies and leukoencephalopathies","volume":"114","author":"Vanderver","year":"2015","journal-title":"Mol Genet Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2329048X20939003","DOI":"10.1177\/2329048X20939003","article-title":"Expanded phenotypic definition identifies hundreds of potential causative genes for leukodystrophies and leukoencephalopathies","volume":"7","author":"Urbik","year":"2020","journal-title":"Child Neurol Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ymgme.2014.12.434","article-title":"A Clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies","volume":"114","author":"Parikh","year":"2015","journal-title":"Mol Genet Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2017.08.006","article-title":"Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies","volume":"122","author":"Adang","year":"2017","journal-title":"Mol Genet Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/01.wnl.0000343049.00540.c8","article-title":"Invited article: an mri-based approach to the diagnosis of white matter disorders","volume":"72","author":"Schiffmann","year":"2009","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1093\/brain\/awq257","article-title":"Magnetic resonance imaging pattern recognition in hypomyelinating disorders","volume":"133","author":"Steenweg","year":"2010","journal-title":"Brain."},{"key":"B7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.nbd.2015.10.015","article-title":"Hypomyelinating disorders: an mri approach","volume":"87","author":"Barkovich","year":"2016","journal-title":"Neurobiol Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/ana.24650","article-title":"Whole exome sequencing in patients with white matter abnormalities","volume":"79","author":"Vanderver","year":"2016","journal-title":"Ann Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/cge.14037","article-title":"Clinical and genetic spectrum of 104 indian families with central nervous system white matter abnormalities","volume":"100","author":"Kaur","year":"2021","journal-title":"Clin Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s10038-020-00896-5","article-title":"Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing","volume":"66","author":"Yan","year":"2021","journal-title":"J Hum Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-0036-1588020","article-title":"Update on leukodystrophies: a historical perspective and adapted definition","volume":"47","author":"Kevelam","year":"2016","journal-title":"Neuropediatrics."},{"key":"B12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/acn3.50957","article-title":"Genome sequencing in persistently unsolved white matter disorders","volume":"7","author":"Helman","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.gim.2022.02.007","article-title":"Genomic answers for children: dynamic analyses of >1000 pediatric rare disease genomes","volume":"24","author":"Cohen","year":"2022","journal-title":"Genet Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41436-018-0075-8","article-title":"Clinical genome sequencing in an unbiased pediatric cohort","volume":"21","author":"Thiffault","year":"2019","journal-title":"Genet Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0209185","DOI":"10.1371\/journal.pone.0209185","article-title":"Increasing the diagnostic yield of exome sequencing by copy number variant analysis","volume":"13","author":"Marchuk","year":"2018","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41436-021-01139-4","article-title":"Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Rehder","year":"2021","journal-title":"Genet Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3389\/fphar.2018.01529","article-title":"Phenotype-driven virtual panel is an effective method to analyze wes data of neurological disease","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/brain\/awx314","article-title":"A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy","volume":"140","author":"Simons","year":"2017","journal-title":"Brain."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/brain\/awy029","article-title":"The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a Cpg hotspot","volume":"141","author":"Yan","year":"2018","journal-title":"Brain."},{"key":"B21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.braindev.2020.06.002","article-title":"A recurrent TMEM106B mutation in hypomyelinating leukodystrophy: a rapid diagnostic assay","volume":"42","author":"Ikemoto","year":"2020","journal-title":"Brain Dev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1212\/WNL.0000000000200228","article-title":"Oculodentodigital dysplasia: a cause of hypomyelinating leukodystrophy in adults","volume":"98","author":"Michell-Robinson","year":"2022","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/154405910808701108","article-title":"Novel mutations in GJA1 cause oculodentodigital syndrome","volume":"87","author":"Fenwick","year":"2008","journal-title":"J Dent Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13059-015-0693-2","article-title":"Comprehensive gene panels provide advantages over clinical exome sequencing for mendelian diseases","volume":"16","author":"Saudi","year":"2015","journal-title":"Genome Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/jmedgenet-2020-107303","article-title":"Personalised virtual gene panels reduce interpretation workload and maintain diagnostic rates of proband-only clinical exome sequencing for rare disorders","volume":"59","author":"Molina-Ram\u00edrez","year":"2022","journal-title":"J Med Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/gim.2017.119","article-title":"Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test","volume":"20","author":"Lionel","year":"2018","journal-title":"Genet Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1586\/14737159.2015.976555","article-title":"Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges","volume":"15","author":"de Koning","year":"2015","journal-title":"Expert Rev Mol Diagn."},{"key":"B28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/gim.2014.122","article-title":"Solving the molecular diagnostic testing conundrum for mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome\/genome sequencing","volume":"17","author":"Xue","year":"2015","journal-title":"Genet Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1086\/346090","article-title":"Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia","volume":"72","author":"Paznekas","year":"2003","journal-title":"Am J Hum Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/hmg\/10.9.983","article-title":"Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations","volume":"10","author":"Saarela","year":"2001","journal-title":"Hum Mol Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/humu.1380050408","article-title":"Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene","volume":"5","author":"Isoniemi","year":"1995","journal-title":"Hum Mutat."},{"key":"B32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0883073820980904","article-title":"Aspartylglucosaminuria: clinical presentation and potential therapies","volume":"36","author":"Goodspeed","year":"2021","journal-title":"J Child Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/TACG.S49590","article-title":"The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis","volume":"8","author":"Wiesinger","year":"2015","journal-title":"Appl Clin Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1093\/nar\/gkv216","article-title":"New insights into the performance of human whole-exome capture platforms","volume":"43","author":"Meienberg","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ajhg.2011.07.014","article-title":"Mutations of POLR3A encoding a catalytic subunit of rna polymerase pol iii cause a recessive hypomyelinating leukodystrophy","volume":"89","author":"Bernard","year":"2011","journal-title":"Am J Hum Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.ajhg.2011.10.003","article-title":"Mutations in POLR3A and POLR3B encoding rna polymerase iii subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy","volume":"89","author":"Saitsu","year":"2011","journal-title":"Am J Hum Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00415-019-09574-9","volume":"267","author":"Infante","year":"2020","journal-title":"J Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13023-015-0279-9","article-title":"Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy","volume":"10","author":"Gutierrez","year":"2015","journal-title":"Orphanet J Rare Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/humu.22813","article-title":"Comparison of exome and genome sequencing technologies for the complete capture of protein-coding regions","volume":"36","author":"Lelieveld","year":"2015","journal-title":"Hum Mutat."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/brain\/awu110","article-title":"Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlation","volume":"137","author":"Hamilton","year":"2014","journal-title":"Brain."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000000535","article-title":"Expanding the phenotypic spectrum of TUBB4A-associated hypomyelinating leukoencephalopathies","volume":"82","author":"Miyatake","year":"2014","journal-title":"Neurology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1212\/WNL.0000000000000754","volume":"83","author":"Pizzino","year":"2014","journal-title":"Neurology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.braindev.2014.05.004","article-title":"A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher disease","volume":"37","author":"Shimojima","year":"2015","journal-title":"Brain Dev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.pediatrneurol.2014.01.051","article-title":"Clinical exome sequencing identifies a novel TUBB4A mutation in a child with static hypomyelinating leukodystrophy","volume":"50","author":"Purnell","year":"2014","journal-title":"Pediatr Neurol."},{"key":"B46","first-page":"237","article-title":"First exons and introns\u2013a survey of GC content and gene structure in the human genome","volume":"6","author":"Kalari","year":"2006","journal-title":"In Silico Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2011-12-2-r18","article-title":"Analyzing and minimizing PCR amplification bias in illumina sequencing libraries","volume":"12","author":"Aird","year":"2011","journal-title":"Genome Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e62856","DOI":"10.1371\/journal.pone.0062856","article-title":"Effects of GC bias in next-generation-sequencing data on de novo genome assembly","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2013-14-5-r51","article-title":"Characterizing and measuring bias in sequence data","volume":"14","author":"Ross","year":"2013","journal-title":"Genome Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1148\/rg.2019180081","article-title":"Adult leukodystrophies: a step-by-step diagnostic approach","volume":"39","author":"Resende","year":"2019","journal-title":"Radiographics."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e912","DOI":"10.1212\/WNL.0000000000013278","article-title":"Diagnosis of genetic white matter disorders by singleton whole-exome and genome sequencing using interactome-driven prioritization","volume":"98","author":"Schl\u00fcter","year":"2022","journal-title":"Neurology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"104551","DOI":"10.1016\/j.ejmg.2022.104551","article-title":"Unclassified white matter disorders: a diagnostic journey requiring close collaboration between clinical and laboratory services","volume":"65","author":"Stutterd","year":"2022","journal-title":"Eur J Med Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/jnnp-2018-319481","article-title":"Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era","volume":"90","author":"Lynch","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S1474-4422(19)30143-7","article-title":"Diagnosis, prognosis, and treatment of leukodystrophies","volume":"18","author":"van der Knaap","year":"2019","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1148377\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:44:05Z","timestamp":1680536645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1148377\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":54,"alternative-id":["10.3389\/fneur.2023.1148377"],"URL":"http:\/\/dx.doi.org\/10.3389\/fneur.2023.1148377","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":["Neurology (clinical)","Neurology"],"published":{"date-parts":[[2023,4,3]]}}} |